1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. mTOR
  4. mTOR Inhibitors

mTOR Inhibitors

mTOR

mTORC1

mTORC2

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

mTOR Inhibitors, Activators & Modulators
Product Name mTOR mTORC1 mTORC2 Purity
Rapamycin  
mTOR, IC50: 0.1 nM (in HEK293 cells )
  99.94%
Everolimus  
mTOR, IC50: 5-6 nM
  99.10%
Torin 1
mTOR, IC50: 3 nM
mTORC1, IC50: 2-10 nM
mTORC2, IC50: 2-10 nM
>99.0%
MHY1485  
mTORC1
mTORC2
99.86%
AZD-8055
mTOR, IC50: 0.8 nM
    99.19%
Gedatolisib
mTOR, IC50: 1.6 nM
    99.68%
PQR530
mTOR, Kd: 0.33 nM
    99.93%
TML-6
mTOR
    98.34%
Sapanisertib
mTOR, IC50: 1 nM
    99.06%
Dactolisib
mTOR, IC50: 20.7 nM
    99.68%
JR-AB2-011    
mTORC2, IC50: 0.36 μM
98.09%
3BDO
mTOR
    99.91%
Vistusertib
mTOR, IC50: 2.81 nM
    98.82%
Temsirolimus  
mTOR, IC50: 1.76 μM
  99.56%
Salidroside
mTOR
    98.63%
PI-103  
mTORC1, IC50: 20 nM
mTORC2, IC50: 83 nM
99.86%
Torin 2
mTOR, IC50: 2.81 nM
mTOR, EC50: 0.25 nM (Cell Assay)
    99.93%
Torkinib
mTOR, IC50: 8 nM
mTORC1, IC50: 30 nM
mTORC2, IC50: 58 nM
98.76%
PF-04691502
mTOR, Ki: 16 nM
    99.64%
Samotolisib
mTOR, IC50: 165 nM
    99.77%
L-Leucine  
mTORC1
  >98.0%
Omipalisib  
mTORC1, Ki: 0.18 nM
mTORC2, Ki: 0.3 nM
99.31%
OSI-027
mTOR, IC50: 4 nM
mTORC1, IC50: 22 nM
mTORC2, IC50: 65 nM
99.40%
Dihydromyricetin  
mTORC1
mTORC2
99.79%
Ridaforolimus  
mTOR
  >98.0%
Apitolisib
mTOR, Ki: 17 nM
    98.26%
Dactolisib Tosylate
mTOR, IC50: 20.7 nM
    99.88%
Bimiralisib
mTOR, IC50: 89 nM
    98.74%
PP121
mTOR, IC50: 10 nM
    99.08%
CC-115
mTOR, IC50: 21 nM
    96.64%
mTOR inhibitor-3
mTOR, Ki: 1.5 nM
    98.54%
Voxtalisib
mTOR, IC50: 157 nM
mTORC1, IC50: 160 nM
mTORC2, IC50: 910 nM
99.46%
PQR620  
mTORC1
mTORC2
98.06%
BGT226 maleate
mTOR
    99.76%
VS-5584
mTOR, IC50: 37 nM
    98.01%
RapaLink-1
mTOR
    >98.0%
GSK1059615
mTOR, IC50: 12 nM
    >99.0%
PKI-402
mTOR, IC50: 3 nM
    99.79%
PI-103 Hydrochloride  
mTORC1, IC50: 20 nM
mTORC2, IC50: 83 nM
98.06%
CZ415
mTOR, pIC50: 8.07
    98.43%
ETP-46464
mTOR, IC50: 0.6 nM
    98.01%
GNE-317
mTOR
    99.31%
WYE-132
mTOR, IC50: 0.19 nM
    99.40%
WYE-354
mTOR, IC50: 5 nM
    98.00%
CC-223
mTOR, IC50: 16 nM
    99.43%
GNE-477
mTOR, Ki: 21 nM
    95.81%
GDC-0349
mTOR, Ki: 3.8 nM
    98.20%
HDACs/mTOR Inhibitor 1
mTOR, IC50: 1.2 nM
    99.12%
XL388
mTOR, IC50: 9.9 nM
    99.25%
WAY-600
mTOR, IC50: 9 nM
    95.12%
PI3K/mTOR Inhibitor-2
mTOR, IC50: 4.7 nM
    99.45%
PF-04979064
mTOR, Ki: 1.42 nM
    99.75%
Arnicolide D
mTOR
    >99.0%
Palomid 529  
TORC1
TORC2
99.47%
NSC781406
mTOR, IC50: 5.4 nM
    99.91%
(+)-Usnic acid  
mTORC1
mTORC2
>99.0%
CC-115 hydrochloride
mTOR, IC50: 21 nM
    97.22%
Hederacolchiside A1
mTOR
    99.69%
MT 63-78  
mTORC1
 
GNE-493
mTOR, IC50: 30 nM
    95.12%
WYE-687 dihydrochloride
mTOR, IC50: 7 nM
    >98.0%
Rotundic acid
mTOR